Skip to main content
Paul Szabolcs, MD, Pediatric Hematology & Oncology, Cherry Tree, PA, UPMC Children's Hospital of Pittsburgh

PaulSzabolcsMD

Pediatric Hematology & Oncology Cherry Tree, PA

Professor, Pediatrics, Immunology, University of Pittsburgh School of Medicine

Dr. Szabolcs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Szabolcs' full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1990 - 1993
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Pediatrics, 1987 - 1990
  • Semmelweis University
    Semmelweis UniversityClass of 1985

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2011 - 2024
  • NC State Medical License
    NC State Medical License 1998 - 2012

Awards, Honors, & Recognition

  • Lisa Stafford Memorial Research Prize Duke University Comprehensive Cancer Center, 2000
  • Best Student of the Year Pecs University of Medical Sciences, 1990
  • 1st Prize for Critical Thesis Pecs University of Medical Sciences, 1980

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Tolerance After Lung and Bone Marrow Transplantation from an Unrelated Cadaveric Donor  
    Buckley R, Davis R, Moffet J, Voynow J, Jeyaraj A, Chen X, Sempowski G, Zaas D, Journal of Allergy and Clinical Immunology, 1/1/2015
  • IL-7 permits Th1/Tc1 maturation of cord blood T cells while enhances ex vivo expansion in collaboration with CD3/CD28 costimulatory beads and Il-2: A critical step tow...  
    Davis CC, Marti L, Sempowski G, Jeyaraj DA, Cancer Research, 1/1/2010
  • Superior depletion of alloreactive T cells from PBSC and umbilical cord blood grafts by the combined use of trimetrexate and IL-2 immunotoxin  
    Park KD, Marti L, DeOliveira D, Lee Y, Colvin MO, Kurtzberg J, Biology of Blood and Marrow Transplantation, 1/1/2004
  • Join now to see all

Press Mentions

  • Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved Health Equity
    Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved Health EquityApril 25th, 2022
  • Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual Meeting
    Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual MeetingDecember 11th, 2021
  • Rockton Man Gets Approved for Extremely Rare, Life Saving Surgery
    Rockton Man Gets Approved for Extremely Rare, Life Saving SurgeryJuly 8th, 2021
  • Join now to see all

Grant Support

  • CADAVERIC DONOR LUNG AND BONE MARROW TRANSPLANTATION IN IMMUNODEFICIENCY DISEASESNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES2016–2021
  • Graft Engineering And Immunotherapy After Unrelated Cord Blood TransplantationNational Cancer Institute2011
  • Immune Reconstitution After Cord Blood TransplantationNational Heart, Lung, And Blood Institute2009–2011
  • Graft Engineering And Immunotherapy After Unrelated Cord Blood TransplantationNational Cancer Institute2007–2010
  • Immune Reconstitution After Cord Blood TransplantationNational Heart, Lung, And Blood Institute2008
  • CTL Generation By Retrovirus Transduced Dendritic CellNational Institute Of Allergy And Infectious Diseases1994–1996

Professional Memberships

Other Languages

  • Hungarian

Hospital Affiliations